Evidence map›Paper›PMID 30953351›Full record

ArticleJournal of cellular physiology2019

C1q/TNF-related protein-9 promotes macrophage polarization and improves cardiac dysfunction after myocardial infarction.

Mingxin Liu, Lin Yin, Wei Li, Juan Hu, Huibo Wang, Bingjie Ye, Yanhong Tang, Congxin Huang

Open access · hybridAbstract read
In one paragraph

Article in Journal of cellular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Unveiling the roles of CTRP family in cardiac remodeling.Journal of molecular medicine (Berlin, Germany) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The mMolecular and cellular biochemistry · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Mingxin LiuDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Lin YinDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Wei LiDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Juan HuDepartment of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Huibo WangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Bingjie YeDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Yanhong TangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Congxin HuangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.ORCID 0000-0003-4116-4776
Wuhan University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The timely regulation of inflammatory M1 macrophage polarization toward regenerative M2 macrophages suggests the possibility of immunotherapy after myocardial infarction (MI). C1q/TNF-related protein-9 (CTRP9) has anti-inflammatory effects and can ameliorate heart function in mice after long-term myocardial infarction. The role of CTRP9 in macrophage polarization remains completely unclear. This study determined whether CTRP9 can preserve post-MI early cardiac function through the regulation of macrophage polarization. In the present study, an adenovirus-delivered CTRP9 supplement promoted macrophage polarization at Day 3 post MI and improved cardiac function at Day 7 post MI. Pretreatment with gCTRP9 promoted the M1 to M2 polarization transition and attenuated inflammation after lipopolysaccharide + interferon-γ stimulation; the effects were partly abrogated by the adenosine monophosphate kinase (AMPK) inhibitor compound C and were obviously reinforced by pyrrolidine dithiocarbamate, a nuclear factor-κB (NF-κB) inhibitor. Meanwhile, CTPR9 markedly reduced the expression of toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88), and NF-κB p65 phosphorylation by promoting AMPK phosphorylation in vivo and in vitro. Moreover, the competitive binding of gCTRP9 and LPS to the myeloid differentiation protein 2 (MD2)/TLR4 complex was associated with direct binding to MD2, thereby inhibiting the downstream signaling molecule MyD88. Taken together, we demonstrated that CTRP9 improved post-MI early cardiac function, at least in part, by modulating M1/M2 macrophage polarization, largely via the TLR4/MD2/MyD88 and AMPK-NF-κB pathways.

Indexed as

Cell PolarityAdenoviridaeAdenylate KinaseAdiponectinAnimalsCytokinesEnzyme ActivationGlycoproteinsInflammationInterferon-gammaLipopolysaccharidesMacrophage ActivationMacrophagesMaleMyeloid Differentiation Factor 88Myocardial InfarctionAdenylate KinaseAdiponectinC1qtnf9 protein, ratCytokinesGlycoproteinsInterferon-gammaLipopolysaccharidesMyeloid Differentiation Factor 88Toll-Like Receptor 4cardiac functionCTRP9inflammationmacrophage polarizationmyocardial infarction

Identifiers

PMID30953351
PMCPMC6618013
OpenAlexW2972423861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.